Novel FoodGerman company aims for the first EU approval for cell-cultured meatThe Cultivated B ist the first company in the world to apply for EU-Novel-Food authorisation of a hotdog made from plant protein and cultivated muscle cells. more ➔
Alzheimer'sResearchers stop brain cell death in Alzheimer’s miceA Belgian-British research team has identified the human protein underlying necroptosis of human brain cells in Alzheimer’s mice and stopped cell death. more ➔
M&APierre Fabre Laboratories acquires Vertical BioFrench pharma company Pierre Fabre Laboratories has baged Vertical Bio to push development of the company’s NSCLC candidate. more ➔ C more ➔
FinancingBioLamina AB bags €19m funding for expansionFrench-US-based investment specialist Lauxera Capital Partners announced today that it has invested €17m in Swedish cell culture company BioLamina AB (BioLamina) more ➔
radiopharmaceuticalRadiotherapy R&D partnershipOrano Med SAS and Orbit Discovery Ltd announced a collaboration to develop Peptide Receptor Radionuclide Therapies for cancer cells and develop novel radiopharmaceuticals. more ➔
Tech transferBioInnovation Institute Boosts Six Life Science CompaniesNon-profit foundation BioInnovation Institute (BII) has unveiled its latest commitment to driving innovation and growth within the life science sector. Six promising companies will receive crucial financial … more ➔
NGTMajority of EU agri-council supports NGT deregulationAt a council meeting, a majority of EU agriculture ministers have supported the draft regulation on new genomic technologies (NGT) proposed by the EU Commission in early July. more ➔
New detection method for protein degraders German researchers have developed a new way to detect the about 300 cullin-RING ligases (CRLs) which specifically trigger destruction of specific proteins in the cell. more ➔
ScienceStudy: New breeding methods hardly contribute to climate protectionAccording to Swiss bioethicists, deregulation of genetic engineering rules for plants optimised through targeted mutation and cisgenetics will make little contribution to climate protection by 2050. more ➔
vaccinesCEPI commits up to US$80m to University of Oxford to develop vaccinesThe Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford have entered into a strategic partnership to accelerate the development of globally accessible vaccines against … more ➔
